Cindy Motz
Stock Analyst at Goldman Sachs
(0.30)
# 3,985
Out of 4,789 analysts
19
Total ratings
17.65%
Success rate
-17.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cindy Motz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Upgrades: Neutral | $64 → $77 | $87.05 | -11.55% | 3 | Oct 21, 2022 | |
| ACCD Accolade | Maintains: Buy | $15 → $16 | $6.99 | +128.90% | 5 | Oct 7, 2022 | |
| HCAT Health Catalyst | Maintains: Buy | $29 → $18 | $4.33 | +315.70% | 5 | Aug 10, 2022 | |
| DOCS Doximity | Maintains: Buy | $53 → $46 | $56.72 | -18.90% | 3 | Aug 8, 2022 | |
| TDOC Teladoc Health | Downgrades: Neutral | $55 → $36 | $7.76 | +363.92% | 3 | Jul 28, 2022 |
HealthEquity
Oct 21, 2022
Upgrades: Neutral
Price Target: $64 → $77
Current: $87.05
Upside: -11.55%
Accolade
Oct 7, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $6.99
Upside: +128.90%
Health Catalyst
Aug 10, 2022
Maintains: Buy
Price Target: $29 → $18
Current: $4.33
Upside: +315.70%
Doximity
Aug 8, 2022
Maintains: Buy
Price Target: $53 → $46
Current: $56.72
Upside: -18.90%
Teladoc Health
Jul 28, 2022
Downgrades: Neutral
Price Target: $55 → $36
Current: $7.76
Upside: +363.92%